Practical application of natriuretic peptides in paediatric cardiology

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Practical application of natriuretic peptides in paediatric cardiology. / Smith, Julie; Goetze, Jens P; Andersen, Claus B; Vejlstrup, Niels.

In: Cardiology in the Young, Vol. 20, No. 4, 01.08.2010, p. 353-63.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Smith, J, Goetze, JP, Andersen, CB & Vejlstrup, N 2010, 'Practical application of natriuretic peptides in paediatric cardiology', Cardiology in the Young, vol. 20, no. 4, pp. 353-63. https://doi.org/10.1017/S1047951110000211

APA

Smith, J., Goetze, J. P., Andersen, C. B., & Vejlstrup, N. (2010). Practical application of natriuretic peptides in paediatric cardiology. Cardiology in the Young, 20(4), 353-63. https://doi.org/10.1017/S1047951110000211

Vancouver

Smith J, Goetze JP, Andersen CB, Vejlstrup N. Practical application of natriuretic peptides in paediatric cardiology. Cardiology in the Young. 2010 Aug 1;20(4):353-63. https://doi.org/10.1017/S1047951110000211

Author

Smith, Julie ; Goetze, Jens P ; Andersen, Claus B ; Vejlstrup, Niels. / Practical application of natriuretic peptides in paediatric cardiology. In: Cardiology in the Young. 2010 ; Vol. 20, No. 4. pp. 353-63.

Bibtex

@article{527d3cb606d041f1a6e46bb8ffe07c09,
title = "Practical application of natriuretic peptides in paediatric cardiology",
abstract = "It is still uncertain if cardiac natriuretic peptides are useful biomarkers in paediatric cardiology. In this review we identify four clinical scenarios in paediatric cardiology, where clinical decision-making can be difficult, and where we feel the paediatric cardiologists need additional diagnostic tools. Natriuretic peptide measurements could be that extra tool. We discuss and suggest N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide reference intervals for children without cardiovascular disease and cut-off points for the four specific paediatric heart conditions. We conclude that in premature neonates with persistent arterial ducts; in teenagers with tetralogy of Fallot and pulmonary regurgitation; and in children with heart transplants and potential allograft rejection cardiac peptides can provide the clinician with additional information, but in children with atrial septal defects the peptides are not helpful in guiding treatment or follow-up.",
author = "Julie Smith and Goetze, {Jens P} and Andersen, {Claus B} and Niels Vejlstrup",
year = "2010",
month = aug,
day = "1",
doi = "http://dx.doi.org/10.1017/S1047951110000211",
language = "English",
volume = "20",
pages = "353--63",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Practical application of natriuretic peptides in paediatric cardiology

AU - Smith, Julie

AU - Goetze, Jens P

AU - Andersen, Claus B

AU - Vejlstrup, Niels

PY - 2010/8/1

Y1 - 2010/8/1

N2 - It is still uncertain if cardiac natriuretic peptides are useful biomarkers in paediatric cardiology. In this review we identify four clinical scenarios in paediatric cardiology, where clinical decision-making can be difficult, and where we feel the paediatric cardiologists need additional diagnostic tools. Natriuretic peptide measurements could be that extra tool. We discuss and suggest N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide reference intervals for children without cardiovascular disease and cut-off points for the four specific paediatric heart conditions. We conclude that in premature neonates with persistent arterial ducts; in teenagers with tetralogy of Fallot and pulmonary regurgitation; and in children with heart transplants and potential allograft rejection cardiac peptides can provide the clinician with additional information, but in children with atrial septal defects the peptides are not helpful in guiding treatment or follow-up.

AB - It is still uncertain if cardiac natriuretic peptides are useful biomarkers in paediatric cardiology. In this review we identify four clinical scenarios in paediatric cardiology, where clinical decision-making can be difficult, and where we feel the paediatric cardiologists need additional diagnostic tools. Natriuretic peptide measurements could be that extra tool. We discuss and suggest N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide reference intervals for children without cardiovascular disease and cut-off points for the four specific paediatric heart conditions. We conclude that in premature neonates with persistent arterial ducts; in teenagers with tetralogy of Fallot and pulmonary regurgitation; and in children with heart transplants and potential allograft rejection cardiac peptides can provide the clinician with additional information, but in children with atrial septal defects the peptides are not helpful in guiding treatment or follow-up.

U2 - http://dx.doi.org/10.1017/S1047951110000211

DO - http://dx.doi.org/10.1017/S1047951110000211

M3 - Journal article

VL - 20

SP - 353

EP - 363

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - 4

ER -

ID: 34132079